A client is receiving orlistat as part of a weight management program. Which ongoing assessment should be included in the plan of care to determine the effectiveness of the medication?
Depression screening.
Daily calorie count.
Body mass index (BMI).
Serum protein levels.
The Correct Answer is C
Choice A Reason:
Depression screening is important for overall health and well-being, especially in weight management programs where mental health can significantly impact outcomes. However, it is not the primary measure for determining the effectiveness of orlistat. Orlistat works by inhibiting the absorption of fats from the diet, leading to weight loss. Therefore, while mental health monitoring is crucial, it does not directly measure the medication’s effectiveness.
Choice B Reason:
Daily calorie count is a useful tool in weight management programs to ensure that clients are adhering to a calorie-restricted diet. However, it is not a direct measure of the effectiveness of orlistat. While calorie counting can help manage weight, the primary goal of orlistat is to reduce fat absorption, which is better reflected in changes in body weight and BMI.
Choice C Reason:
Body mass index (BMI) is a key indicator of weight management and is directly related to the effectiveness of orlistat. BMI is calculated based on height and weight, providing a clear measure of changes in body weight over time. Monitoring BMI helps determine if the client is losing weight as expected, making it the most appropriate assessment for evaluating the effectiveness of orlistat.
Choice D Reason:
Serum protein levels are important for assessing nutritional status and overall health. However, they do not directly measure the effectiveness of orlistat in a weight management program. Orlistat’s primary function is to reduce fat absorption, and its effectiveness is better assessed through changes in body weight and BMI rather than serum protein levels.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is D
Explanation
Choice A Reason:
Nausea is a common side effect of many medications, including metoclopramide. While it is important to monitor, it is not the most critical adverse effect to report. Metoclopramide is often prescribed to manage nausea, so experiencing this symptom may indicate the need for dosage adjustment or additional supportive care, but it is not an emergency.
Choice B Reason:
Diarrhea is another common side effect of metoclopramide. It can be uncomfortable and may require management, but it is not typically life-threatening. The nurse should monitor the client and provide supportive care, but this side effect does not necessitate immediate reporting unless it becomes severe or persistent.
Choice C Reason:
Unusual irritability can occur with metoclopramide use. While it is important to note changes in mood or behavior, this symptom is not as critical as some other potential adverse effects. The nurse should monitor the client and consider discussing this symptom with the healthcare provider, but it is not the most urgent concern.
Choice D Reason:
Involuntary movements, such as those seen in tardive dyskinesia, are a serious adverse effect of metoclopramide. Tardive dyskinesia is a potentially irreversible condition characterized by repetitive, involuntary movements, often of the face and tongue. This side effect is significant and requires immediate reporting to the healthcare provider, as it may necessitate discontinuation of the medication and further evaluation.
Correct Answer is C
Explanation
Choice A Reason:
Reports of increased energy levels and decreased fatigue are subjective indicators of improvement in anemia symptoms. While these reports are important and suggest that the client is feeling better, they do not provide objective evidence of the effectiveness of epoetin alfa. Hemoglobin levels are a more precise measure of the medication’s impact on anemia.
Choice B Reason:
A food diary showing increased consumption of iron-rich foods indicates that the client is making dietary changes to support their anemia treatment. However, this does not directly measure the effectiveness of epoetin alfa. The medication’s primary goal is to stimulate red blood cell production, which is best assessed through hemoglobin levels.
Choice C Reason:
An increase in hemoglobin level to 12 g/dL (7.45 mmol/L) is an objective indicator that epoetin alfa is effective. Hemoglobin levels are a direct measure of the red blood cell count and oxygen-carrying capacity of the blood. An increase in hemoglobin levels indicates that the medication is successfully treating the anemia associated with CKD.
Choice D Reason:
Taking concurrent iron therapy without adverse effects is important for overall treatment adherence and minimizing side effects. However, it does not directly indicate the effectiveness of epoetin alfa. The primary measure of effectiveness is the improvement in hemoglobin levels.